• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

40 years of percutaneous coronary intervention: where next?

出版信息

Lancet. 2017 Aug 19;390(10096):715. doi: 10.1016/S0140-6736(17)32238-9.

DOI:10.1016/S0140-6736(17)32238-9
PMID:28831978
Abstract
摘要

相似文献

1
40 years of percutaneous coronary intervention: where next?经皮冠状动脉介入治疗40年：未来何去何从？
Lancet. 2017 Aug 19;390(10096):715. doi: 10.1016/S0140-6736(17)32238-9.
2
Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention.接受冠状动脉造影和介入治疗且有长期抗凝指征患者的围手术期及中期抗栓策略
Coron Artery Dis. 2007 May;18(3):193-9. doi: 10.1097/MCA.0b013e328012a964.
3
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.药物洗脱支架经皮冠状动脉介入治疗与旁路手术治疗 3 支血管病变或左主干病变患者的成本效益：紫杉醇药物洗脱支架与心脏手术（SYNTAX）试验的最终结果。
Circulation. 2014 Sep 30;130(14):1146-57. doi: 10.1161/CIRCULATIONAHA.114.009985. Epub 2014 Aug 1.
4
Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.稳定多血管冠状动脉疾病患者随机接受手术、血管成形术或药物治疗的 10 年结果：Medicine, Angioplasty, or Surgery Study II 试验中年龄的影响。
J Thorac Cardiovasc Surg. 2013 Nov;146(5):1105-12. doi: 10.1016/j.jtcvs.2012.08.015. Epub 2012 Aug 31.
5
Long-term follow-up of a randomized, controlled clinical trial of three therapeutic strategies for multivessel stable coronary artery disease in women.一项针对女性多支血管稳定型冠状动脉疾病三种治疗策略的随机对照临床试验的长期随访
Interact Cardiovasc Thorac Surg. 2014 Dec;19(6):997-1001. doi: 10.1093/icvts/ivu288. Epub 2014 Sep 2.
6
Does off-pump or minimally invasive coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with percutaneous coronary intervention? A meta-analysis of randomized trials.与经皮冠状动脉介入治疗相比，非体外循环或微创冠状动脉搭桥术是否能降低死亡率、发病率和资源利用？一项随机试验的荟萃分析。
J Thorac Cardiovasc Surg. 2007 Mar;133(3):623-31. doi: 10.1016/j.jtcvs.2006.11.019.
7
Motivation is a crucial factor for adherence to a healthy lifestyle among people with coronary heart disease after percutaneous coronary intervention.动机是经皮冠状动脉介入治疗后冠心病患者坚持健康生活方式的关键因素。
J Adv Nurs. 2015 Oct;71(10):2364-73. doi: 10.1111/jan.12708. Epub 2015 Jun 18.
8
Percutaneous intervention versus coronary bypass surgery for patients older than 70 years of age with high-risk unstable angina.70岁以上高危不稳定型心绞痛患者的经皮介入治疗与冠状动脉搭桥手术对比
Ann Thorac Surg. 2005 Oct;80(4):1340-6. doi: 10.1016/j.athoracsur.2005.03.057.
9
Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).三维分叉角度对左主干冠状动脉疾病经皮冠状动脉介入治疗后 5 年预后的影响：SYNTAX 试验（紫杉醇药物洗脱支架与心脏搭桥术的联合治疗）的一项亚组研究。
JACC Cardiovasc Interv. 2013 Dec;6(12):1250-60. doi: 10.1016/j.jcin.2013.08.009.
10
[Initial results and long-term outcome of percutaneous coronary intervention in patients with previous coronary artery bypass grafting].[既往接受冠状动脉旁路移植术患者经皮冠状动脉介入治疗的初始结果及长期预后]
J Cardiol. 2001 Sep;38(3):111-21.

引用本文的文献

1
Drug-coated Balloons in the Neurovascular Setting: A Comprehensive, Systematic Review of Current Use and Indications.神经血管领域中的药物涂层球囊：当前应用与适应症的全面系统综述
Rev Cardiovasc Med. 2022 Apr 2;23(4):128. doi: 10.31083/j.rcm2304128. eCollection 2022 Apr.
2
Circulating miR-660-5p is associated with no-reflow phenomenon in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.循环 miR-660-5p 与行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者无复流现象相关。
Anatol J Cardiol. 2021 May;25(5):323-329. doi: 10.14744/AnatolJCardiol.2020.29267.
3
A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction.
基于 Apelin-12 的列线图预测 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后主要不良心血管事件。
Cardiovasc Ther. 2020 Feb 6;2020:9416803. doi: 10.1155/2020/9416803. eCollection 2020.
4
Prognostic Value of Pre-Infarction Angina Combined with Mean Platelet Volume to Lymphocyte Count Ratio for No-Reflow and Short-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.梗死后心绞痛联合血小板平均体积与淋巴细胞计数比值对行经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者无复流和短期死亡率的预测价值。
Med Sci Monit. 2020 Jan 7;26:e919300. doi: 10.12659/MSM.919300.
5
The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.可溶性 ST2 水平升高可预测行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死无复流现象。
J Atheroscler Thromb. 2019 Nov 1;26(11):970-978. doi: 10.5551/jat.48413. Epub 2019 Apr 18.
6
The association between CD69 and EGR1 levels, and CHD patients without reflow after PCI.CD69与EGR1水平之间的关联，以及PCI术后无复流的冠心病患者。
Exp Ther Med. 2019 May;17(5):3913-3920. doi: 10.3892/etm.2019.7411. Epub 2019 Mar 19.
7
The Value of Pre-Infarction Angina and Plasma D-Dimer in Predicting No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients.梗死后心绞痛和血浆 D-二聚体对 ST 段抬高型急性心肌梗死患者直接经皮冠状动脉介入治疗无复流的预测价值。
Med Sci Monit. 2018 Jul 1;24:4528-4535. doi: 10.12659/MSM.909360.